Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of a Novel Compound with Anti-Venezuelan Equine Encephalitis Virus Activity That Targets the Nonstructural Protein 2

26 Jun 2014

Abstract excerpt

Alphaviruses present serious health threats as emerging and re-emerging viruses. Venezuelan equine encephalitis virus (VEEV), a New World alphavirus, can cause encephalitis in humans and horses, but there are no therapeutics for treatment. To date, compounds reported as anti-VEEV or anti-alphavirus inhibitors have shown moderate activity. To discover new classes of anti-VEEV inhibitors with novel viral targets,...

Topics

Join the communities discussing this publication.

HIV Research and Treatment
Mosquito-borne diseases and control
Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24967809
DOI: 10.1371/journal.ppat.1004213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of a Novel Compound with Anti-Venezuelan Equine Encephalitis Virus Activity That Targets the Nonstructural Protein 2PMID 24967809Read ↗

Understanding host responses to equine encephalitis virus infection: implications for therapeutic developmentSemantic proximity Read ↗

A Novel Compound, ML336, Inhibits VEEV Replication by Interfering with Viral RNA SynthesisSemantic proximity Read ↗

Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus.Semantic proximity Read ↗

The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infectionSemantic proximity Read ↗

Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3Semantic proximity Read ↗

Impact of Mutations Affecting 4’-Fluorouridine Susceptibility on Fitness and Treatment Outcomes for Venezuelan Equine Encephalitis VirusSemantic proximity Read ↗

β-d-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome.Semantic proximity Read ↗

Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus InfectionsSemantic proximity Read ↗

Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.Semantic proximity Read ↗

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infectionSemantic proximity Read ↗

Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infectionSemantic proximity Read ↗

Discovery of Dengue Virus NS4B InhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.